Loading compound...

Small molecule cancer research compound

LY-2584702 is a small molecule drug currently being studied in clinical research. It is being investigated for its potential to treat various types of cancer, including renal cell carcinoma and non-small cell lung carcinoma.

How it worksLY-2584702 is a small molecule that works by targeting specific biological processes related to cancer growth and spread.

Used for
Renal cell carcinoma (kidney cancer)Non-small cell lung carcinoma (lung cancer)Neuroendocrine neoplasmsCancer metastasis (the spread of cancer)General cancer research
Conditions
Renal cell carcinomaNon-small cell lung carcinomaNeuroendocrine neoplasmCancer metastasis
Class
Small moleculeSmall molecule cancer research compoundOncology

How to take

This compound is currently in the research phase (Max Phase 1) and is not yet an approved medication for general use.

Talk to your doctor

Questions to ask

  • ·Is LY-2584702 part of any clinical trials I might qualify for?
  • ·How does LY-2584702 differ from current kidney cancer treatments?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.